BioSpace News Archive

Today, Cure SMA and Parent Project Muscular Dystrophy (PPMD), two of the world’s leading rare disease patient advocacy organizations, announced their strategic collaboration to advance clinical data aggregation and reaffirmed their commitment to improving health outcomes for those affected by spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (Duchenne).

VALBIOTIS (FR0013254851 – ALVAL / PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, today announced the appointment of Agnès TIXIER to the Supervisory Board.

World’s-First Ultra-High Resolution CT System Delivers Twice the Resolution of Today’s CT Systems

Zenabis Global Inc. has signed its first exclusive, definitive supply agreement under its Zen Craft Grow program.

I-Mab Biopharma announced dosing of the first healthy subject in a Phase 1 trial in the U.S. of TJM2, a humanized immunoglobulin G1 antibody targeting granulocyte-macrophage colony-stimulating factor.

Next-stage trials in Japan present market launch opportunities for RepliCel’s skin and tendon products

Therapix Biosciences Ltd. announced that the Company has appointed Ambassador Ron Prosor as a global growth strategy and international business development advisor.

Rothman Orthopaedic Institute, an affiliate of Northwell Health, agreed to a two-year partnership with the BIG EAST Conference.

Titan Medical Inc. is pleased to announce that yesterday it filed and was receipted for a final short form prospectus in connection with the previously announced marketed offering of units of the Company.

Intouch Solutions has opened a downtown Boston office at 99 Summer St. and hired Ann Cave, senior vice president, to lead the charge.